PubMed:18483878
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-154 | Sentence | denotes | Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. |
| T2 | 155-267 | Sentence | denotes | Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways. |
| T3 | 268-414 | Sentence | denotes | VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis. |
| T4 | 415-572 | Sentence | denotes | Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis. |
| T5 | 573-799 | Sentence | denotes | A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h). |
| T6 | 800-1032 | Sentence | denotes | Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h). |
| T7 | 1033-1184 | Sentence | denotes | The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made. |
| T8 | 1185-1286 | Sentence | denotes | Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1. |
| T9 | 1287-1611 | Sentence | denotes | CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase). |
| T10 | 1612-1750 | Sentence | denotes | The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP. |
| T11 | 1751-1925 | Sentence | denotes | This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways. |
| T1 | 0-154 | Sentence | denotes | Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. |
| T2 | 155-267 | Sentence | denotes | Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways. |
| T3 | 268-414 | Sentence | denotes | VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis. |
| T4 | 415-572 | Sentence | denotes | Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis. |
| T5 | 573-799 | Sentence | denotes | A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h). |
| T6 | 800-1032 | Sentence | denotes | Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h). |
| T7 | 1033-1184 | Sentence | denotes | The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made. |
| T8 | 1185-1286 | Sentence | denotes | Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1. |
| T9 | 1287-1611 | Sentence | denotes | CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase). |
| T10 | 1612-1750 | Sentence | denotes | The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP. |
| T11 | 1751-1925 | Sentence | denotes | This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways. |
LitCoin-entities-OrganismTaxon-PD
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 104-108 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T3 | 277-281 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T5 | 496-500 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T7 | 575-580 | OrganismTaxon | denotes | mouse | NCBItxid:10090|NCBItxid:10088 |
| T9 | 733-737 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T11 | 805-811 | OrganismTaxon | denotes | binary | NCBItxid:2775475 |
| T12 | 1417-1421 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T14 | 1450-1454 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T16 | 1646-1650 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
| T18 | 1833-1837 | OrganismTaxon | denotes | mice | NCBItxid:10095|NCBItxid:10088 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-154 | Sentence | denotes | Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. |
| T2 | 155-267 | Sentence | denotes | Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide distributed in micturition pathways. |
| T3 | 268-414 | Sentence | denotes | VIP(-/-) mice exhibit altered bladder function and neurochemical properties in micturition pathways after cyclophosphamide (CYP)-induced cystitis. |
| T4 | 415-572 | Sentence | denotes | Given VIP's role as an anti-inflammatory mediator, we hypothesized that VIP(-/-) mice would exhibit enhanced inflammatory mediator expression after cystitis. |
| T5 | 573-799 | Sentence | denotes | A mouse inflammatory cytokine and receptor RT2 profiler array was used to determine regulated transcripts in the urinary bladder of wild type (WT) and VIP(-/-) mice with or without CYP-induced cystitis (150 mg/kg; i.p.; 48 h). |
| T6 | 800-1032 | Sentence | denotes | Four binary comparisons were made: WT control versus CYP treatment (48 h), VIP(-/-) control versus CYP treatment (48 h), WT control versus VIP(-/-) control, and WT with CYP treatment (48 h) versus VIP(-/-) with CYP treatment (48 h). |
| T7 | 1033-1184 | Sentence | denotes | The genes presented represent (1) greater than 1.5-fold change in either direction and (2) the p value is less than 0.05 for the comparison being made. |
| T8 | 1185-1286 | Sentence | denotes | Several regulated genes were validated using enzyme-linked immunoassays including IL-1beta and CXCL1. |
| T9 | 1287-1611 | Sentence | denotes | CYP treatment significantly (p < or = 0.001) increased expression of CXCL1 and IL-1beta in the urinary bladder of WT and VIP(-/-) mice, but expression in VIP(-/-) mice with CYP treatment was significantly (p < or = 0.001) greater (4.2- to 13-fold increase) than that observed in WT urinary bladder (3.6- to 5-fold increase). |
| T10 | 1612-1750 | Sentence | denotes | The data suggest that in VIP(-/-) mice with bladder inflammation, inflammatory mediators are increased above that observed in WT with CYP. |
| T11 | 1751-1925 | Sentence | denotes | This shift in balance may contribute to increased bladder dysfunction in VIP(-/-) mice with bladder inflammation and altered neurochemical expression in micturition pathways. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 5099 | 26-38 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 5100 | 52-85 | GeneOrGeneProduct | denotes | vasoactive intestinal polypeptide | NCBIGene:22353 |
| 5101 | 96-99 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5102 | 104-108 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5103 | 114-130 | ChemicalEntity | denotes | cyclophosphamide | MESH:D003520 |
| 5104 | 132-135 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5105 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | MESH:D003556 |
| 5106 | 155-188 | GeneOrGeneProduct | denotes | Vasoactive intestinal polypeptide | NCBIGene:22353 |
| 5107 | 190-193 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5108 | 268-271 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5109 | 277-281 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5110 | 374-390 | ChemicalEntity | denotes | cyclophosphamide | MESH:D003520 |
| 5111 | 392-395 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5112 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | MESH:D003556 |
| 5113 | 421-424 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5114 | 443-455 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 5115 | 487-490 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5116 | 496-500 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5117 | 524-536 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 5118 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | MESH:D003556 |
| 5119 | 575-580 | OrganismTaxon | denotes | mouse | NCBITaxon:10090 |
| 5120 | 581-593 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 5121 | 724-727 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5122 | 733-737 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5123 | 754-757 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5124 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | MESH:D003556 |
| 5125 | 853-856 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5126 | 875-878 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5127 | 899-902 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5128 | 939-942 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5129 | 969-972 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5130 | 997-1000 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5131 | 1011-1014 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5132 | 1267-1275 | GeneOrGeneProduct | denotes | IL-1beta | NCBIGene:16176 |
| 5133 | 1280-1285 | GeneOrGeneProduct | denotes | CXCL1 | NCBIGene:14825 |
| 5134 | 1287-1290 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5135 | 1356-1361 | GeneOrGeneProduct | denotes | CXCL1 | NCBIGene:14825 |
| 5136 | 1366-1374 | GeneOrGeneProduct | denotes | IL-1beta | NCBIGene:16176 |
| 5137 | 1408-1411 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5138 | 1417-1421 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5139 | 1441-1444 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5140 | 1450-1454 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5141 | 1460-1463 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5142 | 1637-1640 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5143 | 1646-1650 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5144 | 1656-1676 | DiseaseOrPhenotypicFeature | denotes | bladder inflammation | MESH:D003556 |
| 5145 | 1678-1690 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 5146 | 1746-1749 | ChemicalEntity | denotes | CYP | MESH:D003520 |
| 5147 | 1801-1820 | DiseaseOrPhenotypicFeature | denotes | bladder dysfunction | MESH:D001745 |
| 5148 | 1824-1827 | GeneOrGeneProduct | denotes | VIP | NCBIGene:22353 |
| 5149 | 1833-1837 | OrganismTaxon | denotes | mice | NCBITaxon:10090 |
| 5150 | 1843-1863 | DiseaseOrPhenotypicFeature | denotes | bladder inflammation | MESH:D003556 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T2 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T3 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T4 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 52-85 | GeneOrGeneProduct | denotes | vasoactive intestinal polypeptide |
| T2 | 86-94 | GeneOrGeneProduct | denotes | knockout |
| T3 | 155-188 | GeneOrGeneProduct | denotes | Vasoactive intestinal polypeptide |
| T4 | 218-230 | GeneOrGeneProduct | denotes | neuropeptide |
| T5 | 456-464 | GeneOrGeneProduct | denotes | mediator |
| T6 | 537-545 | GeneOrGeneProduct | denotes | mediator |
| T7 | 607-615 | GeneOrGeneProduct | denotes | receptor |
| T8 | 1084-1088 | GeneOrGeneProduct | denotes | fold |
| T9 | 1230-1236 | GeneOrGeneProduct | denotes | enzyme |
| T10 | 1267-1275 | GeneOrGeneProduct | denotes | IL-1beta |
| T11 | 1280-1285 | GeneOrGeneProduct | denotes | CXCL1 |
| T12 | 1356-1361 | GeneOrGeneProduct | denotes | CXCL1 |
| T13 | 1366-1374 | GeneOrGeneProduct | denotes | IL-1beta |
| T14 | 1529-1533 | GeneOrGeneProduct | denotes | fold |
| T15 | 1596-1600 | GeneOrGeneProduct | denotes | fold |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 39-48 | GeneOrGeneProduct | denotes | mediators |
| T2 | 52-85 | GeneOrGeneProduct | denotes | vasoactive intestinal polypeptide |
| T3 | 86-94 | GeneOrGeneProduct | denotes | knockout |
| T4 | 104-108 | GeneOrGeneProduct | denotes | mice |
| T5 | 137-144 | GeneOrGeneProduct | denotes | induced |
| T6 | 155-188 | GeneOrGeneProduct | denotes | Vasoactive intestinal polypeptide |
| T7 | 218-230 | GeneOrGeneProduct | denotes | neuropeptide |
| T8 | 277-281 | GeneOrGeneProduct | denotes | mice |
| T9 | 397-404 | GeneOrGeneProduct | denotes | induced |
| T10 | 456-464 | GeneOrGeneProduct | denotes | mediator |
| T11 | 496-500 | GeneOrGeneProduct | denotes | mice |
| T12 | 537-545 | GeneOrGeneProduct | denotes | mediator |
| T13 | 607-615 | GeneOrGeneProduct | denotes | receptor |
| T14 | 647-656 | GeneOrGeneProduct | denotes | determine |
| T15 | 657-666 | GeneOrGeneProduct | denotes | regulated |
| T16 | 667-678 | GeneOrGeneProduct | denotes | transcripts |
| T17 | 733-737 | GeneOrGeneProduct | denotes | mice |
| T18 | 758-765 | GeneOrGeneProduct | denotes | induced |
| T19 | 780-782 | GeneOrGeneProduct | denotes | mg |
| T20 | 1084-1088 | GeneOrGeneProduct | denotes | fold |
| T21 | 1116-1123 | GeneOrGeneProduct | denotes | and (2) |
| T22 | 1130-1135 | GeneOrGeneProduct | denotes | value |
| T23 | 1193-1202 | GeneOrGeneProduct | denotes | regulated |
| T24 | 1230-1236 | GeneOrGeneProduct | denotes | enzyme |
| T25 | 1237-1243 | GeneOrGeneProduct | denotes | linked |
| T26 | 1267-1275 | GeneOrGeneProduct | denotes | IL-1beta |
| T27 | 1280-1285 | GeneOrGeneProduct | denotes | CXCL1 |
| T28 | 1356-1361 | GeneOrGeneProduct | denotes | CXCL1 |
| T29 | 1366-1374 | GeneOrGeneProduct | denotes | IL-1beta |
| T30 | 1417-1421 | GeneOrGeneProduct | denotes | mice |
| T31 | 1450-1454 | GeneOrGeneProduct | denotes | mice |
| T32 | 1529-1533 | GeneOrGeneProduct | denotes | fold |
| T33 | 1596-1600 | GeneOrGeneProduct | denotes | fold |
| T34 | 1646-1650 | GeneOrGeneProduct | denotes | mice |
| T35 | 1691-1700 | GeneOrGeneProduct | denotes | mediators |
| T36 | 1756-1761 | GeneOrGeneProduct | denotes | shift |
| T37 | 1833-1837 | GeneOrGeneProduct | denotes | mice |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 26-38 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T2 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T3 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T4 | 443-455 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T5 | 524-536 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T6 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T7 | 581-593 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T8 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T9 | 1664-1676 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 |
| T10 | 1678-1690 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T11 | 1851-1863 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 52-85 | GeneOrGeneProduct | denotes | vasoactive intestinal polypeptide |
| T2 | 96-99 | GeneOrGeneProduct | denotes | VIP |
| T3 | 155-188 | GeneOrGeneProduct | denotes | Vasoactive intestinal polypeptide |
| T4 | 190-193 | GeneOrGeneProduct | denotes | VIP |
| T5 | 218-230 | GeneOrGeneProduct | denotes | neuropeptide |
| T6 | 268-271 | GeneOrGeneProduct | denotes | VIP |
| T7 | 487-490 | GeneOrGeneProduct | denotes | VIP |
| T8 | 594-615 | GeneOrGeneProduct | denotes | cytokine and receptor |
| T9 | 724-727 | GeneOrGeneProduct | denotes | VIP |
| T10 | 875-878 | GeneOrGeneProduct | denotes | VIP |
| T11 | 939-942 | GeneOrGeneProduct | denotes | VIP |
| T12 | 997-1000 | GeneOrGeneProduct | denotes | VIP |
| T13 | 1267-1275 | GeneOrGeneProduct | denotes | IL-1beta |
| T14 | 1280-1285 | GeneOrGeneProduct | denotes | CXCL1 |
| T15 | 1356-1361 | GeneOrGeneProduct | denotes | CXCL1 |
| T16 | 1366-1374 | GeneOrGeneProduct | denotes | IL-1beta |
| T17 | 1408-1411 | GeneOrGeneProduct | denotes | VIP |
| T18 | 1441-1444 | GeneOrGeneProduct | denotes | VIP |
| T19 | 1637-1640 | GeneOrGeneProduct | denotes | VIP |
| T20 | 1824-1827 | GeneOrGeneProduct | denotes | VIP |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T2 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T3 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T4 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T2 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T3 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
| T4 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | 0006032 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 26-38 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T2 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T3 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T4 | 443-455 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T5 | 524-536 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T6 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T7 | 581-593 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T8 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T9 | 1664-1676 | DiseaseOrPhenotypicFeature | denotes | inflammation | DISEASE|D007249 |
| T11 | 1678-1690 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T12 | 1801-1820 | DiseaseOrPhenotypicFeature | denotes | bladder dysfunction | DISEASE |
| T13 | 1851-1863 | DiseaseOrPhenotypicFeature | denotes | inflammation | DISEASE|D007249 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T2 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T3 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T4 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 |
| T5 | 1664-1676 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 |
| T6 | 1801-1820 | DiseaseOrPhenotypicFeature | denotes | bladder dysfunction | DISEASE |
| T7 | 1851-1863 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 104-108 | OrganismTaxon | denotes | mice |
| T2 | 277-281 | OrganismTaxon | denotes | mice |
| T3 | 496-500 | OrganismTaxon | denotes | mice |
| T4 | 575-580 | OrganismTaxon | denotes | mouse |
| T5 | 733-737 | OrganismTaxon | denotes | mice |
| T6 | 805-811 | OrganismTaxon | denotes | binary |
| T7 | 1417-1421 | OrganismTaxon | denotes | mice |
| T8 | 1450-1454 | OrganismTaxon | denotes | mice |
| T9 | 1646-1650 | OrganismTaxon | denotes | mice |
| T10 | 1833-1837 | OrganismTaxon | denotes | mice |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 74-85 | ChemicalEntity | denotes | polypeptide | http://purl.obolibrary.org/obo/CHEBI_15841 |
| T2 | 96-99 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T3 | 114-130 | ChemicalEntity | denotes | cyclophosphamide | D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026 |
| T6 | 132-135 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T8 | 177-188 | ChemicalEntity | denotes | polypeptide | http://purl.obolibrary.org/obo/CHEBI_15841 |
| T9 | 190-193 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T10 | 268-271 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T11 | 374-390 | ChemicalEntity | denotes | cyclophosphamide | D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026 |
| T14 | 392-395 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T16 | 487-490 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T17 | 724-727 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T18 | 754-757 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T20 | 853-856 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T22 | 875-878 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T23 | 899-902 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T25 | 939-942 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T26 | 969-972 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T28 | 997-1000 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T29 | 1011-1014 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T31 | 1287-1290 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T33 | 1408-1411 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T34 | 1441-1444 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T35 | 1460-1463 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T37 | 1637-1640 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
| T38 | 1746-1749 | ChemicalEntity | denotes | CYP | http://purl.obolibrary.org/obo/CHEBI_38559|D003520 |
| T40 | 1824-1827 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T40 | 1824-1827 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T38 | 1746-1749 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T37 | 1637-1640 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T35 | 1460-1463 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T34 | 1441-1444 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T33 | 1408-1411 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T31 | 1287-1290 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T29 | 1011-1014 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T28 | 997-1000 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T26 | 969-972 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T25 | 939-942 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T23 | 899-902 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T22 | 875-878 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T20 | 853-856 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T18 | 754-757 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T17 | 724-727 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T16 | 487-490 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T14 | 392-395 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T11 | 374-390 | ChemicalEntity | denotes | cyclophosphamide | http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520 | |
| T10 | 268-271 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T9 | 190-193 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T8 | 177-188 | ChemicalEntity | denotes | polypeptide | http://purl.obolibrary.org/obo/CHEBI_15841 | |
| T6 | 132-135 | ChemicalEntity | denotes | CYP | D003520|http://purl.obolibrary.org/obo/CHEBI_38559 | |
| T3 | 114-130 | ChemicalEntity | denotes | cyclophosphamide | http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520 | |
| T2 | 96-99 | ChemicalEntity | denotes | VIP | http://purl.obolibrary.org/obo/CHEBI_80331 | |
| T1 | 74-85 | ChemicalEntity | denotes | polypeptide | http://purl.obolibrary.org/obo/CHEBI_15841 | |
| T91871 | 1824-1827 | GeneOrGeneProduct | denotes | VIP | ||
| T19 | 1637-1640 | GeneOrGeneProduct | denotes | VIP | ||
| T32084 | 1441-1444 | GeneOrGeneProduct | denotes | VIP | ||
| T98000 | 1408-1411 | GeneOrGeneProduct | denotes | VIP | ||
| T46918 | 1366-1374 | GeneOrGeneProduct | denotes | IL-1beta | ||
| T15 | 1356-1361 | GeneOrGeneProduct | denotes | CXCL1 | ||
| T75841 | 1280-1285 | GeneOrGeneProduct | denotes | CXCL1 | ||
| T13 | 1267-1275 | GeneOrGeneProduct | denotes | IL-1beta | ||
| T12 | 997-1000 | GeneOrGeneProduct | denotes | VIP | ||
| T95910 | 939-942 | GeneOrGeneProduct | denotes | VIP | ||
| T18949 | 875-878 | GeneOrGeneProduct | denotes | VIP | ||
| T50674 | 724-727 | GeneOrGeneProduct | denotes | VIP | ||
| T93777 | 594-615 | GeneOrGeneProduct | denotes | cytokine and receptor | ||
| T7 | 487-490 | GeneOrGeneProduct | denotes | VIP | ||
| T71126 | 268-271 | GeneOrGeneProduct | denotes | VIP | ||
| T5 | 218-230 | GeneOrGeneProduct | denotes | neuropeptide | ||
| T4 | 190-193 | GeneOrGeneProduct | denotes | VIP | ||
| T28423 | 155-188 | GeneOrGeneProduct | denotes | Vasoactive intestinal polypeptide | ||
| T15628 | 96-99 | GeneOrGeneProduct | denotes | VIP | ||
| T33665 | 52-85 | GeneOrGeneProduct | denotes | vasoactive intestinal polypeptide | ||
| T18053 | 1851-1863 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 | |
| T58854 | 1801-1820 | DiseaseOrPhenotypicFeature | denotes | bladder dysfunction | DISEASE | |
| T66767 | 1664-1676 | DiseaseOrPhenotypicFeature | denotes | inflammation | D007249 | |
| T27495 | 766-774 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 | |
| T62041 | 563-571 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 | |
| T26767 | 405-413 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 | |
| T14577 | 145-153 | DiseaseOrPhenotypicFeature | denotes | cystitis | D003556 | |
| T46312 | 1833-1837 | OrganismTaxon | denotes | mice | ||
| T62412 | 1646-1650 | OrganismTaxon | denotes | mice | ||
| T84417 | 1450-1454 | OrganismTaxon | denotes | mice | ||
| T84733 | 1417-1421 | OrganismTaxon | denotes | mice | ||
| T13710 | 805-811 | OrganismTaxon | denotes | binary | ||
| T27804 | 733-737 | OrganismTaxon | denotes | mice | ||
| T83307 | 575-580 | OrganismTaxon | denotes | mouse | ||
| T19737 | 496-500 | OrganismTaxon | denotes | mice | ||
| T77533 | 277-281 | OrganismTaxon | denotes | mice | ||
| T46434 | 104-108 | OrganismTaxon | denotes | mice |
bc5cdr-valid-experiment
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 114-130 | Chemical | denotes | cyclophosphamide |
| T2 | 132-135 | Chemical | denotes | CYP |
| T3 | 145-153 | Disease | denotes | cystitis |
| T4 | 374-390 | Chemical | denotes | cyclophosphamide |
| T5 | 392-395 | Chemical | denotes | CYP |
| T6 | 405-413 | Disease | denotes | cystitis |
| T7 | 563-571 | Disease | denotes | cystitis |
| T8 | 754-757 | Chemical | denotes | CYP |
| T9 | 766-774 | Disease | denotes | cystitis |
| T10 | 853-856 | Chemical | denotes | CYP |
| T11 | 899-902 | Chemical | denotes | CYP |
| T12 | 969-972 | Chemical | denotes | CYP |
| T13 | 1011-1014 | Chemical | denotes | CYP |
| T14 | 1287-1290 | Chemical | denotes | CYP |
| T15 | 1460-1463 | Chemical | denotes | CYP |
| T16 | 1656-1676 | Disease | denotes | bladder inflammation |
| T17 | 1746-1749 | Chemical | denotes | CYP |
| T18 | 1801-1820 | Disease | denotes | bladder dysfunction |
| T19 | 1843-1863 | Disease | denotes | bladder inflammation |